Heart Disease Clinical Trials in Atlanta

Showing 441-442 of 442 trials

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

NCT00050765

MyoCell™ implantation by epicardial injection during CABG surgery has the potential to add a new dimension to the management of post-infarct deterioration of cardiac function. Based on existing non-clinical studies and clinical reports, implantation of autologous skeletal myoblasts appears to lead to the replacement of non-functioning myocardial scar with functioning muscle and appears to improve myocardial performance relative to case without myoblast implantation. In a few investigational patients, myoblast implantation can be, and has been, done in conjunction with CABG and appears to have the potential to provide for additive treatment during surgery. The present study is being conducted to evaluate more fully the safety of MyoCell™ implantation via epicardial injection during CABG surgery and its effect on regional myocardial function.

Congestive Heart FailureCoronary Artery DiseaseMyocardial Infarction

Bioheart, Inc.15 participantsStarted Aug 2006

Fort Lauderdale, Florida, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +2 more locations

COMPLETEDPhase 4140 miles

African-American Heart Failure Trial

NCT00047775

A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.

Congestive Heart Failure

Nitromed1,100 participantsStarted May 2001

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Washington D.C., District of Columbia, United States +4 more locations

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

African-American Heart Failure Trial

Heart Disease Trials in Other Cities

Other Conditions in Atlanta